JPRN-UMIN000025191已完成未知
Prospective study of Grazoprevir and Elbasvir for HCV genotype 1 intected Japanese patients - IFN free GE study
Osaka City University and affiliated hospital0 个研究点目标入组 119 人开始时间: 2017年1月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 119
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •Pregnant woman Decompensated cirrhosis hepatocellular carcinoma Doctors judge as inappropriate
研究者
相似试验
已完成
不适用
Safety and efficacy of Grazoprevir and Elbasvir combination therapy for hemodialyzed patients with genotype 1 chronic hepatitis C infectiohemodialyzed patients with chronic hepatitis C infectionJPRN-UMIN000025784Graduate School of Medicine, Hokkaido University60
招募中
不适用
Efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis CJPRN-UMIN000025050Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology500
进行中(未招募)
不适用
Grazoprevir + Elbasvir for the treatment of acute hepatitis C genotype 1/4.The Dutch Acute HCV in HIV Study (DAHHS-2)EUCTR2015-003210-24-BEErasmus MC80
招募中
3 期
Grazoprevir (MK-5172) + Elbasvir (MK-8742) for the treatment of ACUTE hepatitis C genotype 1/4. The Dutch Acute HCV in HIV Study (DAHHS-2)acute hepatitis c1001965410047438NL-OMON43933Erasmus MC, Universitair Medisch Centrum Rotterdam71
招募中
不适用
Evaluation of the efficacy of elbasvir and glazopurevir for Japanese hepatitis C patients: a prospective study in real life settings.JPRN-UMIN000026908Toranomon Hospital100
